Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress

by NASDAQ Market News October 4, 2021

NASDAQ Market News
Click here to email author

Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of Valneva SE (VALN) and Encourages Investors With More Than $50,000 in Losses to Contact the Firm

Ads